We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.19%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$111M
AUM Growth
–
Cap. Flow
+$109M
Cap. Flow
% of AUM
97.8%
Top 10 Holdings %
Top 10 Hldgs %
35.94%
Holding
105
New
105
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$6.57M |
| 2 |
Data I/O
DAIO
|
+$5.31M |
| 3 |
Amazon
AMZN
|
+$4.95M |
| 4 |
ESIO
Electro Scientific Industries
ESIO
|
+$4.42M |
| 5 |
Microsoft
MSFT
|
+$4.25M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.96% |
| 2 | Healthcare | 12.66% |
| 3 | Energy | 10.8% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Meta Platforms (Facebook)
META
$1.5T
| $441K | 0.4% |
+2,500
| New | +$442K |
|
|
BMCH
77
DELISTED
BMC Stock Holdings, Inc
BMCH
| $440K | 0.4% |
+17,400
| New | +$390K |
|
|
PTVCB
78
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $435K | 0.39% |
+18,170
| New | +$423K |
|
79
AbbVie
ABBV
$433B
| $371K | 0.33% |
+3,840
| New | +$362K |
|
|
VIVS
80
VivoSim Labs
VIVS
$1.17M
| $361K | 0.33% |
+1,124
| New | +$418K |
|
81
Baytex Energy
BTE
$3.1B
| $343K | 0.31% |
+114,450
| New | +$337K |
|
82
GE Aerospace
GE
$383B
| $312K | 0.28% |
+3,733
| New | +$356K |
|
83
Aflac
AFL
$64.5B
| $307K | 0.28% |
+7,000
| New | +$299K |
|
|
VRN
84
DELISTED
Veren
VRN
| $300K | 0.27% |
+39,200
| New | +$295K |
|
85
ConocoPhillips
COP
$145B
| $293K | 0.26% |
+5,345
| New | +$275K |
|
|
NYV
86
DELISTED
Nuveen New York Municipal Value Fund 2
NYV
| $287K | 0.26% |
+20,000
| New | +$290K |
|
|
SNCR
87
DELISTED
Synchronoss Technologies
SNCR
| $259K | 0.23% |
+3,220
| New | +$311K |
|
88
IBM
IBM
$213B
| $250K | 0.23% |
+1,705
| New | +$248K |
|
89
Ares Capital
ARCC
$13.8B
| $236K | 0.21% |
+15,025
| New | +$244K |
|
90
General Mills
GIS
$19.2B
| $228K | 0.21% |
+3,840
| New | +$208K |
|
91
Chevron
CVX
$385B
| $221K | 0.2% |
+1,765
| New | +$209K |
|
92
Abbott
ABT
$185B
| $219K | 0.2% |
+3,840
| New | +$213K |
|
93
Fidelity National Information Services
FIS
$23.1B
| $212K | 0.19% |
+2,255
| New | +$212K |
|
94
NGL Energy Partners
NGL
$2B
| $211K | 0.19% |
+15,000
| New | +$185K |
|
|
PTLA
95
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $209K | 0.19% |
+4,300
| New | +$217K |
|
|
CY
96
DELISTED
Cypress Semiconductor
CY
| $184K | 0.17% |
+12,050
| New | +$191K |
|
97
Ford
F
$57.5B
| $160K | 0.14% |
+12,800
| New | +$158K |
|
98
Lightpath Technologies
LPTH
$702M
| $159K | 0.14% |
+71,800
| New | +$199K |
|
|
SEAC
99
DELISTED
Seachange International Inc
SEAC
| $157K | 0.14% |
+2,000
| New | +$118K |
|
100
Invesco Municipal Trust
VKQ
$537M
| $125K | 0.11% |
+10,000
| New | +$125K |
|
Similar funds
IWM
EP
AC
SF
LAM
HAM
HEM
CF
Penbrook Management's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Penbrook Management, which disclosed 105 positions worth $111M. Its ten largest holdings account for 36% of the portfolio.
Its largest position is Novo Nordisk: 258,200 shares worth $6.93M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, followed by Healthcare and Energy.
- Penbrook Management's largest Q4 2017 buy was Novo Nordisk: 258,200 shares worth $6.93M.
- Penbrook Management's ten largest holdings make up 36% of its $111M portfolio in Q4 2017.
- Penbrook Management disclosed 105 positions in Q4 2017, its first 13F filing on record.
Based on Penbrook Management's 13F filing for Q4 2017, filed 21 Feb 2018.